Komori
Japan Lifeline (7575) · InitiativeFirst stated

Entry into the sleep-disordered breathing field

First written in FY2022. . Latest entry: FY2022.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Entry into the sleep-disordered breathing treatment field through a medical deviceA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2022First statedAnnual report

    「In February 2022, the company performed Japan's first case using the Inspire UAS (インスパイア・ユーエーエス) hypoglossal nerve stimulation device, "Inspire UAS," used to treat obstructive sleep apnea. Treatment of sleep-disordered breathing is a new therapeutic area for the company.」

    The company performed Japan's first case using Inspire UAS in February 2022 and began entering the new therapeutic area of sleep-disordered breathing.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Japan Lifeline's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Entry into the sleep-disordered breathing field | Japan Lifeline Co.,Ltd. (7575) | Komori